| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |